M. Toth et al., NITRIC-OXIDE SYNTHASE IN FIRST-TRIMESTER HUMAN PLACENTA - CHARACTERIZATION AND SUBCELLULAR-DISTRIBUTION, Hypertension in pregnancy, 14(3), 1995, pp. 287-300
Objectives: To characterize the activity and subcellular distribution
of nitric oxide synthase (NOS) in primordial human placenta. Methods:
Enzyme activity was assayed in chorion frondosum homogenate and subcel
lular fractions by measuring the conversion of radiolabeled L-arginine
to L-citrulline in the presence or absence of EGTA, NAME (a NOS inhib
itor), and NADPH. Main Outcome Measures: Analysis of NOS activity in f
irst-trimester human placental tissue, in terms of citrulline producti
on that is generated in 1:1 ratio with nitric oxide, a potent vasodila
tor. Results: Both Ca2+-dependent and -independent NOS activities were
detected in whole homogenate, as well as in subcellular fractions. Sp
ecific activity of NOS was highest in the microsomal fraction, where t
he enzyme exhibited an absolute requirement for NADPH. Unexpectedly, b
oth Ca2+-activated and Ca2+-independent activities were insensitive to
the calmodulin antagonist chlorpromazine, while aminoguanidine, a sel
ective inhibitor of the inducible NOS, effectively suppressed Ca2+-dep
endent generation of citrulline. Conclusion: Some of the properties of
the NO-generating enzyme in the primordial placenta. described here f
or the first time, differ in several respects from those reported for
the term placenta. A coordinated local interaction of NO with the immu
ne system of the developing placenta and the prostaglandin-generating
mechanism is suggested, ensuring proper implantation, which may be com
promised in hypertensive pregnancies associated with impaired NO synth
esis.